関連レポート

出版元：Transparency Market Research  出版元について

発行年：2024年9月

定価：Single User License $5795 Multi User License $8795 Corporate User License $11795

ご請求は円換算（お見積り日TTSレート）となります。

ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。

納品形態：PDF by Email

当調査レポートは英文 204ページになります。

商品コード：TMR339

当レポートは発行年月に関わらず、受注の都度、最新情報にアップデートしてお届けいたします。ご希望情報の追加等もご相談可能です。

レポート紹介

ペプチド原薬の世界市場規模は2023年で92億ドル、2034年に942億ドル、市場の平均年成長率は22.4%にて増加する見込みです。

当レポートでは、ペプチド原薬の市場予測-2034年、各種セグメント別市場分析(薬剤クラス別、製品タイプ別、国地域別、等)、市場細分化、主な研究目的、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】
■ペプチド原薬の世界市場予測2020-2034年
・市場規模(US$)

■薬剤クラス別、市場-2034年
・GLP-1受容体作動薬
・インスリン
・その他ペプチドクラス
※(市場規模US$)　

■製品タイプ別、市場-2034年
・GLP-1受容体作動薬経口剤
・GLP-1受容体作動薬注射剤
・インスリン注射剤
・その他ペプチド製剤
※(市場規模US$)　

■投与経路別、市場-2034年
・経口
・非経口
※(市場規模US$)　

■用途別、市場-2034年
・2型糖尿病
・1型糖尿病
・肥満症
・非アルコール性脂肪性肝疾患
・その他
※(市場規模US$)　

■主要国地域別市場-2034年
北米
・米国、カナダ
欧州
アジア太平洋
南米
中東アフリカ

■市場分析
市場細分化
主な研究目的
研究ハイライト
市場ダイナミクス

■ペプチド原薬の主要企業プロフィール動向
Eli Lilly and Company
Sanofi
Novo Nordisk
AstraZeneca
GlaxoSmithKline
PegBio Co. Ltd.
Amgen Inc.
Pfizer Inc.
Innovent Biologics
Sun Pharmaceuticals
Boehringer Ingelheim
Biocon
Wockhardt Ltd.
（全204頁）

Table of Contents (英文詳細目次）

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Peptide API Market

4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Peptide API Market Analysis and Forecasts, 2020-2034
4.4.1. Market Value (US$ Bn) and Volume Projections (Kg)

5. Key Insights
5.1. Epidemiology of Diabetes and Obesity across Key Countries / Regions
5.2. Recent Technological Advancements in GLP-1 Receptor Agonist Therapeutics Industry
5.3. Recent Technological Advancements in Insulin Therapeutics Industry
5.4. GLP-1 Receptor Agonist Therapeutics Pricing Trends
5.5. Insulin Therapeutics Pricing Trends
5.6. Clinical Trials Analysis

6. Global Peptide API Market Analysis and Forecasts, By Drug Class
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value, Volume and Patient Population Forecast By Drug Class, 2020-2034
6.3.1. GLP-1 Receptor Agonist
6.3.2. Insulin
6.3.3. Other Peptide Classes
6.4. Market Attractiveness By Drug Class

7. Global Peptide API Market Analysis and Forecasts, By Product Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value, Volume and Patient Population Forecast By Product Type, 2020-2034
7.3.1. GLP-1 Receptor Agonist Oral Formulations
7.3.2. GLP-1 Receptor Agonist Injectables
7.3.3. Insulin Injectables
7.3.4. Other Peptides
7.4. Market Attractiveness By Product Type

8. Global Peptide API Market Analysis and Forecasts, By Route of Administration
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value, Volume and Patient Population Forecast By Route of Administration, 2020-2034
8.3.1. Oral
8.3.2. Parenteral
8.4. Market Attractiveness By Route of Administration

9. Global Peptide API Market Analysis and Forecasts, By Application
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value, Volume and Patient Population Forecast By Application, 2020-2034
9.3.1. Type 2 Diabetes Mellitus
9.3.2. Type 1 Diabetes
9.3.3. Obesity
9.3.4. Non-alcoholic Fatty Liver Disease
9.3.5. Others
9.4. Market Attractiveness By Application

10. Global Peptide API Market Analysis and Forecasts, By Region
10.1. Key Findings
10.2. Market Value, Volume and Patient Population Forecast By Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Region

11. North America Peptide API Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value, Volume and Patient Population Forecast By Drug Class, 2020-2034
11.2.1. GLP-1 Receptor Agonist
11.2.2. Insulin
11.2.3. Other Peptide Classes
11.3. Market Value, Volume and Patient Population Forecast By Product Type, 2020-2034
11.3.1. GLP-1 Receptor Agonist Oral Formulations
11.3.2. GLP-1 Receptor Agonist Injectables
11.3.3. Insulin Injectables
11.3.4. Other Peptides
11.4. Market Value, Volume and Patient Population Forecast By Route of Administration, 2020-2034
11.4.1. Oral
11.4.2. Parenteral
11.5. Market Value, Volume and Patient Population Forecast By Application, 2020-2034
11.5.1. Type 2 Diabetes Mellitus
11.5.2. Type 1 Diabetes
11.5.3. Obesity
11.5.4. Non-alcoholic Fatty Liver Disease
11.5.5. Others
11.6. Market Value, Volume and Patient Population Forecast By Country, 2020-2034
11.6.1. U.S.
11.6.2. Canada

12. Competition Landscape
12.1. Market Player - Competition Matrix (By Tier and Size of companies)
12.2. Market Share Analysis By Company (2023)
12.3. Competitive Dashboard
12.3.1. By Region
12.3.2. By Drug Class
12.4. Competitive Snapshot
12.5. Company Profiles
12.5.1. Eli Lilly and Company
12.5.1.1. Company Overview
12.5.1.2. Financial Overview
12.5.1.3. Product Portfolio
12.5.1.4. Business Strategies
12.5.1.5. Recent Developments
12.5.2. Sanofi S.A.
12.5.2.1. Company Overview
12.5.2.2. Financial Overview
12.5.2.3. Product Portfolio
12.5.2.4. Business Strategies
12.5.2.5. Recent Developments
12.5.3. Novo Nordisk
12.5.3.1. Company Overview
12.5.3.2. Financial Overview
12.5.3.3. Product Portfolio
12.5.3.4. Business Strategies
12.5.3.5. Recent Developments
12.5.4. AstraZeneca
12.5.4.1. Company Overview
12.5.4.2. Financial Overview
12.5.4.3. Product Portfolio
12.5.4.4. Business Strategies
12.5.4.5. Recent Developments
12.5.5. GlaxoSmithKline
12.5.5.1. Company Overview
12.5.5.2. Financial Overview
12.5.5.3. Product Portfolio
12.5.5.4. Business Strategies
12.5.5.5. Recent Developments
12.5.6. PegBio Co. Ltd.
12.5.6.1. Company Overview
12.5.6.2. Financial Overview
12.5.6.3. Product Portfolio
12.5.6.4. Business Strategies
12.5.6.5. Recent Developments
12.5.7. Amgen Inc.
12.5.7.1. Company Overview
12.5.7.2. Financial Overview
12.5.7.3. Product Portfolio
12.5.7.4. Business Strategies
12.5.7.5. Recent Developments
12.5.8. Pfizer Inc.
12.5.8.1. Company Overview
12.5.8.2. Financial Overview
12.5.8.3. Product Portfolio
12.5.8.4. Business Strategies
12.5.8.5. Recent Developments
12.5.9. Innovent Biologics, Inc.
12.5.9.1. Company Overview
12.5.9.2. Financial Overview
12.5.9.3. Product Portfolio
12.5.9.4. Business Strategies
12.5.9.5. Recent Developments
12.5.10. Sun Pharmaceutical Industries Limited
12.5.10.1. Company Overview
12.5.10.2. Financial Overview
12.5.10.3. Product Portfolio
12.5.10.4. Business Strategies
12.5.10.5. Recent Developments
12.5.11. Boehringer Ingelheim
12.5.11.1. Company Overview
12.5.11.2. Financial Overview
12.5.11.3. Product Portfolio
12.5.11.4. Business Strategies
12.5.11.5. Recent Developments
12.5.12. Biocon Limited
12.5.12.1. Company Overview
12.5.12.2. Financial Overview
12.5.12.3. Product Portfolio
12.5.12.4. Business Strategies
12.5.12.5. Recent Developments
12.5.13. Wockhardt
12.5.13.1. Company Overview
12.5.13.2. Financial Overview
12.5.13.3. Product Portfolio
12.5.13.4. Business Strategies
12.5.13.5. Recent Developments

List of Tables

Table 01: Global Peptide API Market Value (US$ Bn) Forecast, by Drug Class, 2020-2034

Table 02: Global Peptide API Market Volume (Kg) Forecast, by Drug Class, 2020-2034

Table 03: Global Peptide API Market, by Drug Class (Patient Population) (Bn), 2020-2034

Table 04: Global Peptide API Market Value (US$ Bn) Forecast, by Product Type, 2020-2034

Table 05: Global Peptide API Market Volume (Kg) Forecast, by Product Type, 2020-2034

Table 06: Global Peptide API Market, Product Type (Patient Population) (Bn), 2020-2034

Table 07: Global Peptide API Market Value (US$ Bn) Forecast, by Route of Administration, 2020-2034

Table 08: Global Peptide API Market Volume (Kg) Forecast, by Route of Administration, 2020-2034

Table 09: Global Peptide API Market, by Route of Administration (Patient Population) (Bn), 2020-2034

Table 10: Global Peptide API Market Value (US$ Bn) Forecast, by Application, 2020-2034

Table 11: Global Peptide API Market Volume (Kg) Forecast, by Application, 2020-2034

Table 12: Global Peptide API Market, by Application (Patient Population) (Bn), 2020-2034

Table 13: Global Peptide API Market Value (US$ Bn) Forecast, by Region, 2020-2034

Table 14: Global Peptide API Market Volume (Kg) Forecast, by Region, 2020-2034

Table 15: Global Peptide API Market, by Region (Patient Population) (Bn), 2020-2034

Table 16: North America Peptide API Market Value (US$ Bn) Forecast, by Country, 2020-2034

Table 17: North America Peptide API Market Volume (Kg) Forecast, by Country, 2020-2034

Table 18: North America Peptide API Market, (Patient Population) (Bn) 2020-2034

Table 19: North America Peptide API Market Value (US$ Bn) Forecast, by Drug Class, 2020-2034

Table 20: North America Peptide API Market Volume (Kg) Forecast, by Drug Class, 2020-2034

Table 21: North America Peptide API Market, by Drug Class (Patient Population) (Bn), 2020-2034

Table 22: North America Peptide API Market Value (US$ Bn) Forecast, by Product Type, 2020-2034

Table 23: North America Peptide API Market Volume (Kg) Forecast, by Product Type, 2020-2034

Table 24: North America Peptide API Market, Product Type (Patient Population) (Bn), 2020-2034

Table 25: North America Peptide API Market Value (US$ Bn) Forecast, by Route of Administration, 2020-2034

Table 26: North America Peptide API Market Volume (Kg) Forecast, by Route of Administration, 2020-2034

Table 27: North America Peptide API Market, by Route of Administration (Patient Population) (Bn), 2020-2034

Table 28: North America Peptide API Market Volume (Kg) Forecast, by Application, 2020-2034

Table 29: North America Peptide API Market Volume (Kg) Forecast, by Application, 2020-2034

Table 30: North America Peptide API Market, by Application (Patient Population) (Bn), 2020-2034

List of Figures

Figure 01: Global Peptide API Market Value (US$ Bn) Forecast, 2020-2034

Figure 02: Global Peptide API Market Value Share, by Drug Class, 2023

Figure 03: Global Peptide API Market Value Share, by Product Type, 2023

Figure 04: Global Peptide API Market Value Share, by Route of Administration, 2023

Figure 05: Global Peptide API Market Value Share, by Application, 2023

Figure 06: Global Peptide API Market Value Share, by Region, 2023

Figure 07: Global Peptide API Market Value (US$ Bn) Share Analysis, by Drug Class, 2023 and 2034

Figure 08: Global Peptide API Market Share Analysis, by Drug Class, 2023

Figure 09: Global Peptide API Market Share Analysis, by Drug Class, 2034

Figure 10: Global Peptide API Market Volume (Kg) Share Analysis, by Drug Class, 2023 and 2034

Figure 11: Global Peptide API Market Share Analysis, by Drug Class, 2023

Figure 12: Global Peptide API Market Share Analysis, by Drug Class, 2034

Figure 13: Global Peptide API Market Attractiveness Analysis, by Drug Class, 2024-2034

Figure 14: Global Peptide API Market Value (US$ Bn), by GLP-1 Receptor Agonist, 2020-2034

Figure 15: Global Peptide API Market Value Share Analysis, by GLP-1 Receptor Agonist, 2023 and 2034

Figure 16: Global Peptide API Market Value (US$ Bn), by Insulin, 2020-2034

Figure 17: Global Peptide API Market Value Share Analysis, by Insulin, 2023 and 2034

Figure 18: Global Peptide API Market Value (US$ Bn), by Other Peptide Classes, 2020-2034

Figure 19: Global Peptide API Market Value Share Analysis, by Other Peptide Classes, 2023 and 2034

Figure 20: Global Peptide API Market Volume (Kg), by GLP-1 Receptor Agonist, 2020-2034

Figure 21: Global Peptide API Market Volume Share Analysis, by GLP-1 Receptor Agonist, 2023 and 2034

Figure 22: Global Peptide API Market Volume (Kg), by Insulin, 2020-2034

Figure 23: Global Peptide API Market Volume Share Analysis, by Insulin, 2023 and 2034

Figure 24: Global Peptide API Market Volume (Kg), by Other Peptide Classes, 2020-2034

Figure 25: Global Peptide API Market Volume Share Analysis, by Other Peptide Classes, 2023 and 2034

Figure 26: Global Peptide API Market Value (US$ Bn) Share Analysis, by Product Type, 2023 and 2034

Figure 27: Global Peptide API Market Share Analysis, by Product Type, 2023

Figure 28: Global Peptide API Market Share Analysis, by Product Type, 2034

Figure 29: Global Peptide API Market Volume (Kg) Share Analysis, by Product Type, 2023 and 2034

Figure 30: Global Peptide API Market Share Analysis, by Product Type, 2023

Figure 31: Global Peptide API Market Share Analysis, by Product Type, 2034

Figure 32: Global Peptide API Market Attractiveness Analysis, by Product Type, 2024-2034

Figure 33: Global Peptide API Market Value (US$ Bn), by GLP-1 Receptor Agonist Oral Formulations, 2020-2034

Figure 34: Global Peptide API Market Value Share Analysis, by GLP-1 Receptor Agonist Oral Formulations, 2023 and 2034

Figure 35: Global Peptide API Market Value (US$ Bn), by GLP-1 Receptor Agonist Injectable, 2020-2034

Figure 36: Global Peptide API Market Value Share Analysis, by GLP-1 Receptor Agonist Injectables, 2023 and 2034

Figure 37: Global Peptide API Market Value (US$ Bn), by Insulin Injectables, 2020-2034

Figure 38: Global Peptide API Market Value Share Analysis, by Insulin Injectables, 2023 and 2034

Figure 39: Global Peptide API Market Value (US$ Bn), by Other Peptides, 2020-2034

Figure 40: Global Peptide API Market Value Share Analysis, by Other Peptides, 2023 and 2034

Figure 41: Global Peptide API Market Volume (Kg), by GLP-1 Receptor Agonist Oral Formulations, 2020-2034

Figure 42: Global Peptide API Market Value Share Analysis, by GLP-1 Receptor Agonist Oral Formulations, 2023 and 2034

Figure 43: Global Peptide API Market Volume (Kg), by GLP-1 Receptor Agonist Injectable, 2020-2034

Figure 44: Global Peptide API Market Value Share Analysis, by GLP-1 Receptor Agonist Injectables, 2023 and 2034

Figure 45: Global Peptide API Market Volume (Kg), by Insulin Injectables, 2020-2034

Figure 46: Global Peptide API Market Value Share Analysis, by Insulin Injectables, 2023 and 2034

Figure 47: Global Peptide API Market Volume (Kg), by Other Peptides, 2020-2034

Figure 48: Global Peptide API Market Value Share Analysis, by Other Peptides, 2023 and 2034

Figure 49: Global Peptide API Market Value (US$ Bn) Share Analysis, by Route of Administration, 2023 and 2034

Figure 50: Global Peptide API Market Share Analysis, by Route of Administration, 2023

Figure 51: Global Peptide API Market Share Analysis, by Route of Administration, 2034

Figure 52: Global Peptide API Market Volume (Kg) Share Analysis, by Route of Administration, 2023 and 2034

Figure 53: Global Peptide API Market Share Analysis, by Route of Administration, 2023

Figure 54: Global Peptide API Market Share Analysis, by Route of Administration, 2034

Figure 55: Global Peptide API Market Attractiveness Analysis, by Route of Administration, 2024-2034

Figure 56: Global Peptide API Market Value (US$ Bn), by Oral, 2020-2034

Figure 57: Global Peptide API Market Value Share Analysis, by Oral, 2023 and 2034

Figure 58: Global Peptide API Market Value (US$ Bn), by Parenteral, 2020-2034

Figure 59: Global Peptide API Market Value Share Analysis, by Parenteral, 2023 and 2034

Figure 60: Global Peptide API Market Volume (Kg), by Oral, 2020-2034

Figure 61: Global Peptide API Market Value Share Analysis, by Oral, 2023 and 2034

Figure 62: Global Peptide API Market Volume (Kg), by Parenteral, 2020-2034

Figure 63: Global Peptide API Market Value Share Analysis, by Parenteral, 2023 and 2034

Figure 64: Global Peptide API Market Value (US$ Bn) Share Analysis, by Application, 2023 and 2034

Figure 65: Global Peptide API Market Share Analysis, by Application, 2023

Figure 66: Global Peptide API Market Share Analysis, by Application, 2034

Figure 67: Global Peptide API Market Volume (Kg) Share Analysis, by Application, 2023 and 2034

Figure 68: Global Peptide API Market Share Analysis, by Application, 2023

Figure 69: Global Peptide API Market Share Analysis, by Application, 2034

Figure 70: Global Peptide API Market Attractiveness Analysis, by Application, 2024-2034

Figure 71: Global Peptide API Market Value (US$ Bn), by Type 2 Diabetes Mellitus, 2020-2034

Figure 72: Global Peptide API Market Value Share Analysis, by Type 2 Diabetes Mellitus, 2023 and 2034

Figure 73: Global Peptide API Market Value (US$ Bn), by Type 1 Diabetes, 2020-2034

Figure 74: Global Peptide API Market Value Share Analysis, by Type 1 Diabetes, 2023 and 2034

Figure 75: Global Peptide API Market Value (US$ Bn), by Obesity, 2020-2034

Figure 76: Global Peptide API Market Value Share Analysis, by Obesity, 2023 and 2034

Figure 77: Global Peptide API Market Value (US$ Bn), by Non-alcoholic Fatty Liver Disease, 2020-2034

Figure 78: Global Peptide API Market Value Share Analysis, by Non-alcoholic Fatty Liver Disease, 2023 and 2034

Figure 79: Global Peptide API Market Value (US$ Bn), by Others, 2020-2034

Figure 80: Global Peptide API Market Value Share Analysis, by Others, 2023 and 2034

Figure 81: Global Peptide API Market Volume (Kg), by Type 2 Diabetes Mellitus, 2020-2034

Figure 82: Global Peptide API Market Value Share Analysis, by Type 2 Diabetes Mellitus, 2023 and 2034

Figure 83: Global Peptide API Market Volume (Kg), by Type 1 Diabetes, 2020-2034

Figure 84: Global Peptide API Market Value Share Analysis, by Type 1 Diabetes, 2023 and 2034

Figure 85: Global Peptide API Market Volume (Kg), by Obesity, 2020-2034

Figure 86: Global Peptide API Market Value Share Analysis, by Obesity, 2023 and 2034

Figure 87: Global Peptide API Market Volume (Kg), by Non-alcoholic Fatty Liver Disease, 2020-2034

Figure 88: Global Peptide API Market Value Share Analysis, by Non-alcoholic Fatty Liver Disease, 2023 and 2034

Figure 89: Global Peptide API Market Volume (Kg), by Others, 2020-2034

Figure 90: Global Peptide API Market Value Share Analysis, by Others, 2023 and 2034

Figure 91: Global Peptide API Market Value (US$ Bn) Share Analysis, by Region, 2023 and 2034

Figure 92: Global Peptide API Market Share Analysis, by Region, 2023

Figure 93: Global Peptide API Market Share Analysis, by Region, 2034

Figure 94: Global Peptide API Market Volume (Kg) Share Analysis, by Region, 2023 and 2034

Figure 95: Global Peptide API Market Share Analysis, by Region, 2023

Figure 96: Global Peptide API Market Share Analysis, by Region, 2034

Figure 97: Global Peptide API Market Attractiveness Analysis, by Region, 2023-2034

Figure 98: North America Peptide API Market Value (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034

Figure 99: North America Peptide API Market Value Share Analysis, by Country, 2023 and 2034

Figure 100: North America Peptide API Market Attractiveness Analysis, by Country, 2024-2034

Figure 101: North America Peptide API Market Volume (Kg) Forecast and Y-o-Y Growth (%) Projection, 2020-2034

Figure 102: North America Peptide API Market Volume Share Analysis, by Country, 2023 and 2034

Figure 103: North America Peptide API Market Attractiveness Analysis, by Country, 2024-2034

Figure 104: North America Peptide API Market Value (US$ Bn) Share Analysis, by Drug Class, 2023 and 2034

Figure 105: North America Peptide API Market Attractiveness Analysis, by Drug Class, 2024-2034

Figure 106: North America Peptide API Market Volume (Kg) Share Analysis, by Drug Class, 2023 and 2034

Figure 107: North America Peptide API Market Attractiveness Analysis, by Drug Class, 2024-2034

Figure 108: North America Peptide API Market Value (US$ Bn) Share Analysis, by Product Type, 2023 and 2034

Figure 109: North America Peptide API Market Attractiveness Analysis, by Product Type, 2024-2034

Figure 110: North America Peptide API Market Volume (Kg) Share Analysis, by Product Type, 2023 and 2034

Figure 111: North America Peptide API Market Attractiveness Analysis, by Product Type, 2024-2034

Figure 112: North America Peptide API Market Value (US$ Bn) Share Analysis, by Route of Administration, 2023 and 2034

Figure 113: North America Peptide API Market Attractiveness Analysis, by Route of Administration, 2024-2034

Figure 114: North America Peptide API Market Volume (Kg) Share Analysis, by Route of Administration, 2023 and 2034

Figure 115: North America Peptide API Market Attractiveness Analysis, by Route of Administration, 2024-2034

Figure 116: North America Peptide API Market Value (US$ Bn) Share Analysis, by Application, 2023 and 2034

Figure 117: North America Peptide API Market Attractiveness Analysis, by Application, 2024-2034

Figure 118: North America Peptide API Market Volume (Kg) Share Analysis, by Application, 2023 and 2034

Figure 119: North America Peptide API Market Attractiveness Analysis, by Application, 2024-2034

△ 一番上に戻る